Page last updated: 2024-09-02

ramosetron and Cholera Infantum

ramosetron has been researched along with Cholera Infantum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, DW; Liu, YY; Shan, XJ; Xie, XD; Zheng, ZD1
Chen, Y; Liu, YF; Shen, Y; Shen, ZX; Wang, AH; Zeng, XY1

Trials

2 trial(s) available for ramosetron and Cholera Infantum

ArticleYear
[Effects of Nasea on prevention of gastrointestinal side effects caused by chemotherapeutic drugs].
    Zhonghua yi xue za zhi, 2003, Jul-10, Volume: 83, Issue:13

    Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Agents; Benzimidazoles; Female; Gastrointestinal Diseases; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Time Factors; Treatment Outcome; Vomiting

2003
Ramosetron for the management of chemotherapy-induced gastrointestinal events in patients with hematological malignancies.
    Methods and findings in experimental and clinical pharmacology, 2001, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Appetite; Benzimidazoles; Constipation; Dizziness; Drug-Related Side Effects and Adverse Reactions; Female; Flushing; Gastrointestinal Diseases; Headache; Hematologic Neoplasms; Humans; Indoles; Male; Middle Aged; Nausea; Thirst; Treatment Outcome; Tropisetron; Vomiting

2001